|
Schlusskurs
Nasdaq
|
||
| - USD | - |
|
| 22.08.16 | Pfizer bietet Milliarden für Biopharmaspezialisten Medivation | DP |
| 22.08.16 | Amgen : Pfizer kauft US-Krebsspezialisten Medivation für 14 Milliarden Dollar | RE |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| +3.31% | -3.70% | +28.80% | +57.00% | +77.63% | +61.03% | +103.64% | +21.62% | - | 71.35 Mrd. | |
| +2.09% | +2.28% | +11.59% | +29.30% | +25.22% | +49.95% | +91.30% | +206.98% | +6’548.89% | 64.17 Mrd. | |
| -1.31% | -0.50% | +26.00% | +22.02% | +18.24% | +7.41% | -4.29% | -69.58% | - | 28.65 Mrd. | |
| -1.64% | +0.73% | +29.33% | +48.46% | +59.03% | +57.43% | +10.50% | -56.90% | - | 27.33 Mrd. | |
| +0.40% | -4.80% | +16.34% | +14.26% | -28.53% | -5.89% | +469.55% | +381.94% | +840.92% | 27.06 Mrd. | |
| -1.68% | +0.33% | +14.93% | +24.47% | +6.51% | +36.86% | -16.09% | -28.01% | +97.35% | 20.47 Mrd. | |
| +1.02% | +6.43% | +31.28% | +96.76% | +251.66% | +269.42% | +420.34% | +1’917.81% | +966.39% | 19.36 Mrd. | |
| -0.10% | -2.53% | +1.17% | +9.60% | +32.46% | +12.11% | +537.42% | - | - | 15.96 Mrd. | |
| -1.09% | +3.14% | +1.32% | +12.24% | +27.99% | +46.32% | +155.12% | +194.64% | +411.86% | 14.05 Mrd. | |
| +0.27% | -0.32% | +4.11% | +13.27% | +34.24% | +320.77% | +219.31% | +38.90% | +1’182.30% | 12.55 Mrd. | |
| +5.22% | -0.24% | -1.03% | +2.78% | -7.46% | +26.84% | +200.51% | +559.75% | +5’626.67% | 11.83 Mrd. | |
| +2.25% | +1.88% | -1.91% | +3.81% | +24.65% | +107.38% | +127.19% | +150.95% | +547.59% | 10.77 Mrd. | |
| +6.51% | +8.54% | +4.17% | -16.29% | -18.64% | -47.26% | +699.44% | +75.90% | +96.38% | 10.66 Mrd. | |
| +2.60% | +2.72% | -2.18% | -16.28% | -14.65% | -38.57% | +183.68% | +163.89% | - | 10.45 Mrd. | |
| -12.81% | -14.06% | -8.35% | +27.09% | +185.73% | +448.68% | +615.91% | -46.89% | -36.49% | 9.47 Mrd. | |
| 0.00% | -3.49% | +11.76% | +21.91% | +32.40% | +101.95% | +21.48% | +144.36% | - | 9.09 Mrd. | |
| -0.02% | +0.18% | +1.33% | +130.67% | +82.26% | +174.30% | +396.72% | +278.41% | - | 9 Mrd. | |
| +0.73% | +1.48% | +16.20% | +4.17% | +316.67% | +246.64% | +400.00% | -24.31% | - | 8.68 Mrd. | |
| +1.18% | +1.69% | -5.14% | -1.28% | +12.85% | -7.51% | +117.25% | -18.26% | - | 8.57 Mrd. | |
| Durchschnitt | +0.35% | +1.86% | +9.46% | +25.47% | +58.86% | +98.31% | +249.95% | +216.18% | +1’628.19% | 19.47 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | +0.89% | +2.42% | +15.18% | +32.20% | +52.24% | +75.52% | +191.62% | +201.23% | +2’782.01% |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
